Drug intelligence / Profile preview

salicylic acid + adapalene + benzoyl peroxide

Development stage
Preclinical
Lead developer
Galderma
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **topical combination drug** composed of three active ingredients—**salicylic acid**, **adapalene**, and **benzoyl peroxide**—each with distinct mechanisms of action relevant to the treatment of acne vulgaris. - **Salicylic acid** is a beta-hydroxy acid that acts as a keratolytic agent, exfoliating the skin and unclogging pores by increasing the turnover of epidermal cells. - **Adapalene** is a third-generation retinoid that modulates cell differentiation, keratinization, and inflammatory processes of the skin, primarily through agonism of retinoic acid receptors. - **Benzoyl peroxide** is an oxidizing agent with strong antibacterial properties (directly killing Cutibacterium acnes), anti-inflammatory effects, and mild comedolytic (pore-unclogging) actions. Used in combination, these agents synergistically address key acne pathophysiology: reducing follicular hyperkeratinization, suppressing inflammation, and eliminating acne-causing bacteria. This fixed-dose triple agent is typically applied topically and may be found in compounded formulations or as part of certain clinical protocols for moderate to severe acne. No FDA-approved single-brand formulation containing all three exists, but similar triple or dyad combinations are supported in the literature as effective, especially for moderate or resistant acne[1][2].

02

Targets

RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)

Beyond the preview

Go deeper on salicylic acid + adapalene + benzoyl peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylic acid + adapalene + benzoyl peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call